Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-02

Clinical Trial Update: Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immune response to a pneumococcal vaccine in adults treated with alefacept for chronic plaque psoriasis. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alefacept (Alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: COMPLETED